Spectral Medical Inc.
EDT.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 71.75% | 24.36% | 51.10% | 26.47% | -34.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.75% | 24.36% | 51.10% | 26.47% | -34.14% |
| Cost of Revenue | 24.41% | 5.45% | 35.56% | 104.24% | 27.89% |
| Gross Profit | 138.74% | 87.03% | 226.34% | -0.72% | -60.97% |
| SG&A Expenses | -9.98% | 4.09% | 5.44% | 33.04% | 33.65% |
| Depreciation & Amortization | 53.76% | 10.35% | 423.08% | 115.52% | -29.90% |
| Other Operating Expenses | 49.74% | -49.92% | -- | 57.00% | 36.43% |
| Total Operating Expenses | -6.52% | -0.69% | 19.49% | 41.78% | 31.90% |
| Operating Income | 16.35% | 3.95% | -16.91% | -47.38% | -50.90% |
| Income Before Tax | 147.60% | -167.46% | -0.78% | -280.84% | -440.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 147.60% | -167.46% | -0.78% | -280.84% | -440.61% |
| Earnings from Discontinued Operations | 86.88% | -- | -- | 93.08% | 97.72% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 147.32% | -158.33% | -1.95% | -266.72% | -158.22% |
| EBIT | 16.35% | 3.95% | -16.91% | -47.38% | -50.90% |
| EBITDA | 17.13% | 3.81% | -17.04% | -48.83% | -53.85% |
| EPS Basic | 146.20% | -154.90% | -1.77% | -266.67% | -155.22% |
| Normalized Basic EPS | 152.08% | -167.21% | 0.00% | -283.33% | -464.71% |
| EPS Diluted | 146.20% | -154.90% | -1.77% | -266.67% | -155.22% |
| Normalized Diluted EPS | 152.08% | -167.21% | 0.00% | -283.33% | -464.71% |
| Average Basic Shares Outstanding | 1.78% | 1.11% | 0.54% | 0.33% | 1.30% |
| Average Diluted Shares Outstanding | 1.78% | 1.11% | 0.54% | 0.33% | 1.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |